Final Rule Requiring Drug Price Disclosure An Important Step In Lowering Prices For Americans

posted by AHIP

on May 8, 2019

WASHINGTON, D.C. –  Matt Eyles, president and CEO of America’s Health Insurance Plans (AHIP), issued the following statement following the finalization of a rule that will require drug makers to disclose their list prices in consumer-directed television advertising:

“Drug prices are out of control, affecting millions of American families every day. We commend the Administration for taking an important step to shed some light on the ‘black box’ of drug pricing. When patients have a clear view into list prices, which are set and controlled solely by drug makers, they are better empowered to make health care decisions that are right for them.

“As the bargaining power of the American health care consumer, health insurance providers believe that greater transparency from manufacturers into drug prices — how drug makers set those prices, and why they increase prices on the exact same product year after year — is essential to bringing down drug prices and costs for everyone. Everyone should be able to get the medications they need at a price they can afford. With the right solutions and by working together, we can ensure both innovation and affordability for prescription drugs in America.”

" "